Home
/
AMGEN INC
/
Financials
/
Quarterly
AMGEN INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AMGEN INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2021
Jun 30, 2021
$6.53B
Aug 4, 2021
Q1
2021
Mar 31, 2021
$5.90B
Apr 28, 2021
Q3
2020
Sep 30, 2020
$6.42B
Oct 29, 2020
Q2
2021
Jun 30, 2020
$6.21B
Aug 4, 2021
Q1
2021
Mar 31, 2020
$6.16B
Apr 28, 2021
Q3
2020
Sep 30, 2019
$5.74B
Oct 29, 2020
Q2
2020
Jun 30, 2019
$5.87B
Jul 29, 2020
Q1
2020
Mar 31, 2019
$5.56B
May 1, 2020
Q3
2019
Sep 30, 2018
$5.90B
Oct 30, 2019
Q2
2019
Jun 30, 2018
$6.06B
Jul 31, 2019
Q1
2019
Mar 31, 2018
$5.55B
May 1, 2019
Q3
2018
Sep 30, 2017
$5.77B
Oct 31, 2018
Q2
2018
Jun 30, 2017
$5.81B
Jul 27, 2018
Q1
2018
Mar 31, 2017
$5.46B
Apr 25, 2018
Q3
2017
Sep 30, 2016
$5.81B
Oct 26, 2017
Q2
2017
Jun 30, 2016
$5.69B
Jul 26, 2017
Q1
2017
Mar 31, 2016
$5.53B
Apr 27, 2017
Q3
2016
Sep 30, 2015
$5.72B
Oct 28, 2016
Q2
2016
Jun 30, 2015
$5.37B
Jul 29, 2016
Q1
2016
Mar 31, 2015
$5.03B
May 2, 2016
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$9.56B
Nov 5, 2025
Q2
2025
Jun 30, 2025
$9.18B
Aug 6, 2025
Q1
2025
Mar 31, 2025
$8.15B
May 2, 2025
Q3
2025
Sep 30, 2024
$8.50B
Nov 5, 2025
Q2
2025
Jun 30, 2024
$8.39B
Aug 6, 2025
Q1
2025
Mar 31, 2024
$7.45B
May 2, 2025
Q3
2024
Sep 30, 2023
$6.90B
Oct 31, 2024
Q2
2024
Jun 30, 2023
$6.99B
Aug 7, 2024
Q1
2024
Mar 31, 2023
$6.11B
May 3, 2024
Q3
2023
Sep 30, 2022
$6.65B
Oct 31, 2023
Q2
2023
Jun 30, 2022
$6.59B
Aug 4, 2023
Q1
2023
Mar 31, 2022
$6.24B
Apr 28, 2023
Q3
2022
Sep 30, 2021
$6.71B
Nov 4, 2022
Q2
2022
Jun 30, 2021
$6.53B
Aug 5, 2022
Q1
2022
Mar 31, 2021
$5.90B
Apr 28, 2022
Q3
2021
Sep 30, 2020
$6.42B
Nov 3, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.22B
Nov 5, 2025
Q2
2025
Jun 30, 2025
$1.43B
Aug 6, 2025
Q1
2025
Mar 31, 2025
$1.73B
May 2, 2025
Q3
2025
Sep 30, 2024
$2.83B
Nov 5, 2025
Q3
2024
Jun 30, 2024
$746.00M
Oct 31, 2024
Q2
2025
Jun 30, 2024
$746.00M
Aug 6, 2025
Q3
2024
Mar 31, 2024
($113.00M)
Oct 31, 2024
Q2
2024
Mar 31, 2024
($113.00M)
Aug 7, 2024
Q1
2025
Mar 31, 2024
($113.00M)
May 2, 2025
Q3
2024
Sep 30, 2023
$1.73B
Oct 31, 2024
Q2
2024
Jun 30, 2023
$1.38B
Aug 7, 2024
Q3
2024
Jun 30, 2023
$1.38B
Oct 31, 2024
Q3
2024
Mar 31, 2023
$2.84B
Oct 31, 2024
Q2
2024
Mar 31, 2023
$2.84B
Aug 7, 2024
Q1
2024
Mar 31, 2023
$2.84B
May 3, 2024
Q3
2023
Sep 30, 2022
$2.14B
Oct 31, 2023
Q2
2023
Jun 30, 2022
$1.32B
Aug 4, 2023
Q3
2023
Jun 30, 2022
$1.32B
Oct 31, 2023
Q2
2023
Mar 31, 2022
$1.48B
Aug 4, 2023
Q3
2023
Mar 31, 2022
$1.48B
Oct 31, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.53B
Nov 5, 2025
Q2
2025
Jun 30, 2025
$2.66B
Aug 6, 2025
Q1
2025
Mar 31, 2025
$1.18B
May 2, 2025
Q3
2025
Sep 30, 2024
$2.05B
Nov 5, 2025
Q2
2025
Jun 30, 2024
$1.91B
Aug 6, 2025
Q1
2025
Mar 31, 2024
$991.00M
May 2, 2025
Q3
2024
Sep 30, 2023
$2.02B
Oct 31, 2024
Q2
2024
Jun 30, 2023
$2.68B
Aug 7, 2024
Q1
2024
Mar 31, 2023
$1.92B
May 3, 2024
Q3
2023
Sep 30, 2022
$2.66B
Oct 31, 2023
Q2
2023
Jun 30, 2022
$2.18B
Aug 4, 2023
Q1
2023
Mar 31, 2022
$2.50B
Apr 28, 2023
Q3
2022
Sep 30, 2021
$2.38B
Nov 4, 2022
Q2
2022
Jun 30, 2021
$828.00M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$2.13B
Apr 28, 2022
Q3
2021
Sep 30, 2020
$2.45B
Nov 3, 2021
Q2
2021
Jun 30, 2020
$2.32B
Aug 4, 2021
Q1
2021
Mar 31, 2020
$2.36B
Apr 28, 2021
Q3
2020
Sep 30, 2019
$2.48B
Oct 29, 2020
Q2
2020
Jun 30, 2019
$2.68B
Jul 29, 2020